Drug Discovery in the Next Millennium

Author:

Ohlstein Eliot H.1,Ruffolo Jr Robert R.1,Elliott John D.1

Affiliation:

1. Departments of Cardiovascular Pharmacology and Medicinal Chemistry, Research & Development, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406–0939;, ,

Abstract

Selection and validation of novel molecular targets have become of paramount importance in light of the plethora of new potential therapeutic drug targets that have emerged from human gene sequencing. In response to this revolution within the pharmaceutical industry, the development of high-throughput methods in both biology and chemistry has been necessitated. This review addresses these technological advances as well as several new areas that have been created by necessity to deal with this new paradigm, such as bioinformatics, cheminformatics, and functional genomics. With many of these key components of future drug discovery now in place, it is possible to map out a critical path for this process that will be used into the new millennium.

Publisher

Annual Reviews

Subject

Pharmacology,Toxicology

Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Design, Synthesis and Molecular Docking Studies of New Indole Scaffolds;Asian Journal of Organic Chemistry;2024-07-24

2. Current Trends in the Development and Biochemistry of Drugs;Recent Advances in Industrial Biochemistry;2024

3. DaiCee: A database for anti-cancer compounds with targets and side effect profiles;Bioinformation;2020-11-30

4. Discovery of CCL18 antagonist blocking breast cancer metastasis;Clinical & Experimental Metastasis;2019-05-06

5. Step I: Target Identification;Chemical Sciences in Early Drug Discovery;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3